 |
Refuge Biotechnologies
Bing C. Wang - Co-Founder, Chief Executive Officer
USA | Funding: $33.9M (+)
Website: https://refugebiotech.com/
A discovery-stage therapeutic company focused on gene editing and genetic engineering of immune cells for cancer immunotherapy.
Website: https://refugebiotech.com/
A discovery-stage therapeutic company focused on gene editing and genetic engineering of immune cells for cancer immunotherapy.
